The court directed Sebi to decide on US resident Digvijay ‘Danny’ Gaekwad’s proposed competing offer in accordance with the ...

Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned as an independent director from Religare Enterprises due to ...

Florida-based businessman Danny Gaekwad seeks Trump administration intervention after lack of response from Indian regulators ...

Florida businessman Danny Gaekwad persists in his bid for control of Religare Enterprises, challenging the current open offer ...

A division bench of the Delhi High Court on Thursday rejected an appeal by Dr. Rashmi Saluja, the Executive Chairman of ...

As the Burman family's open offer for Religare looms, a competing bid from Digvijay Gaekwad adds complexity to the situation.

Gaekwad sought for a special exemption under takeover from the Securities and Exchange Board of India to make an open offer ...

Care Health Insurance, India’s second-largest standalone health insurer and Religare’s most valuable asset, has been growing ...

Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned from Religare Enterprises' board due to increasing workload in his family business. The resignation comes amidst a contentious open offer ...

Saluja had filed the petition in the high court citing the resolution is illegal and that it violates the Companies Act 2013 ...

India's Religare Enterprises said a U.S. businessman has made a proposal to acquire a 26% stake in it, the latest twist in ...

While declining interim relief, the court directed SEBI to swiftly decide on a competing takeover bid, keeping the stage set ...